
Photocure ASA
OSE:PHO.OL
50.1 (NOK) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Photocure ASA |
Symbool | PHO.OL |
Munteenheid | NOK |
Prijs | 54 |
Beurswaarde | 1,463,707,800 |
Dividendpercentage | 0% |
52-weken bereik | 40.7 - 115 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Daniel Schneider |
Website | https://www.photocure.com |
An error occurred while fetching data.
Over Photocure ASA
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (NOK)
Cijfers zijn in miljoenen (NOK)